urethane has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Compared to free GA, the optimized PEUU nanocarrier improves the intratumoral distribution of GA by more than 9-fold, which significantly enhances the bioavailability and persistence of GA after intravenous administration." | 1.91 | Optimization of amino acid-based poly(ester urea urethane) nanoparticles for the systemic delivery of gambogic acid for treating triple negative breast cancer. ( Bian, Z; Chu, CC; Ji, Y; Kwan, HY; Li, J; Xiao, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y | 1 |
| Li, J | 1 |
| Xiao, S | 1 |
| Kwan, HY | 1 |
| Bian, Z | 1 |
| Chu, CC | 1 |
1 other study available for urethane and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Optimization of amino acid-based poly(ester urea urethane) nanoparticles for the systemic delivery of gambogic acid for treating triple negative breast cancer.
Topics: Amino Acids; Animals; Esters; Humans; Mice; Nanoparticles; Triple Negative Breast Neoplasms; Urea; U | 2023 |